New Psychoactive Substances (eBook, PDF)
Pharmacology, Clinical, Forensic and Analytical Toxicology
160,49 €
inkl. MwSt.
Sofort per Download lieferbar
0 °P sammeln
New Psychoactive Substances (eBook, PDF)
Pharmacology, Clinical, Forensic and Analytical Toxicology
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 12.62MB
Andere Kunden interessierten sich auch für
- Anxiety and Anxiolytic Drugs (eBook, PDF)227,95 €
- Toxicological Effects of Perfluoroalkyl and Polyfluoroalkyl Substances (eBook, PDF)139,09 €
- Concepts and Principles of Pharmacology (eBook, PDF)171,19 €
- Non-canonical Cyclic Nucleotides (eBook, PDF)287,83 €
- Heart Failure (eBook, PDF)245,03 €
- Antidepressants (eBook, PDF)149,79 €
- Voltage-gated Sodium Channels: Structure, Function and Channelopathies (eBook, PDF)149,79 €
-
-
-
Produktdetails
- Produktdetails
- Verlag: Springer International Publishing
- Erscheinungstermin: 20. Februar 2019
- Englisch
- ISBN-13: 9783030105617
- Artikelnr.: 55284755
- Verlag: Springer International Publishing
- Erscheinungstermin: 20. Februar 2019
- Englisch
- ISBN-13: 9783030105617
- Artikelnr.: 55284755
Preface.- Part I General Aspects.- 1. Self-Experiments with Psychoactive Substances: A Historical Perspective.- 2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.- 3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective.- 4. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.- Part II Drug Classes.- 5. Neuropharmacology of Synthetic Cathinones.- 6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.- 7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.- 8. Molecular pharmacology of synthetic cannabinoids: Evolution.- 9. Synthetic Opioids.- 10. Designer Benzodiazepines: Another Class of New Psychoactive Substances.- 11. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.- 12. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.- 13. Phencyclidine-Based New Psychoactive Substances.- Part III Clinical, Forensic, and Analytical Toxicology.- 14. Bioanalytical Methods for New Psychoactive Substances.- 15. Wastewater Analysis for Community-Wide Drugs Use Assessment.- 16. Toxicokinetics of NPS: Update 2017.- 17. Patterns of Acute Toxicity Associated with New Psychoactive Substances.- 18. Fatal Poisonings Associated with New Psychoactive Substances.
Preface.- Part I General Aspects.- 1. Self-Experiments with Psychoactive Substances: A Historical Perspective.- 2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.- 3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective.- 4. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.- Part II Drug Classes.- 5. Neuropharmacology of Synthetic Cathinones.- 6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.- 7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.- 8. Molecular pharmacology of synthetic cannabinoids: Evolution.- 9. Synthetic Opioids.- 10. Designer Benzodiazepines: Another Class of New Psychoactive Substances.- 11. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.- 12. 1,2-Diarylethylamine- and Ketamine-Based New PsychoactiveSubstances.- 13. Phencyclidine-Based New Psychoactive Substances.- Part III Clinical, Forensic, and Analytical Toxicology.- 14. Bioanalytical Methods for New Psychoactive Substances.- 15. Wastewater Analysis for Community-Wide Drugs Use Assessment.- 16. Toxicokinetics of NPS: Update 2017.- 17. Patterns of Acute Toxicity Associated with New Psychoactive Substances.- 18. Fatal Poisonings Associated with New Psychoactive Substances.
Preface.- Part I General Aspects.- 1. Self-Experiments with Psychoactive Substances: A Historical Perspective.- 2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.- 3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective.- 4. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.- Part II Drug Classes.- 5. Neuropharmacology of Synthetic Cathinones.- 6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.- 7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.- 8. Molecular pharmacology of synthetic cannabinoids: Evolution.- 9. Synthetic Opioids.- 10. Designer Benzodiazepines: Another Class of New Psychoactive Substances.- 11. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.- 12. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances.- 13. Phencyclidine-Based New Psychoactive Substances.- Part III Clinical, Forensic, and Analytical Toxicology.- 14. Bioanalytical Methods for New Psychoactive Substances.- 15. Wastewater Analysis for Community-Wide Drugs Use Assessment.- 16. Toxicokinetics of NPS: Update 2017.- 17. Patterns of Acute Toxicity Associated with New Psychoactive Substances.- 18. Fatal Poisonings Associated with New Psychoactive Substances.
Preface.- Part I General Aspects.- 1. Self-Experiments with Psychoactive Substances: A Historical Perspective.- 2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures.- 3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective.- 4. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.- Part II Drug Classes.- 5. Neuropharmacology of Synthetic Cathinones.- 6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances.- 7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins.- 8. Molecular pharmacology of synthetic cannabinoids: Evolution.- 9. Synthetic Opioids.- 10. Designer Benzodiazepines: Another Class of New Psychoactive Substances.- 11. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action.- 12. 1,2-Diarylethylamine- and Ketamine-Based New PsychoactiveSubstances.- 13. Phencyclidine-Based New Psychoactive Substances.- Part III Clinical, Forensic, and Analytical Toxicology.- 14. Bioanalytical Methods for New Psychoactive Substances.- 15. Wastewater Analysis for Community-Wide Drugs Use Assessment.- 16. Toxicokinetics of NPS: Update 2017.- 17. Patterns of Acute Toxicity Associated with New Psychoactive Substances.- 18. Fatal Poisonings Associated with New Psychoactive Substances.